With the global cost of dementia care projected to exceed US$2.8 trillion by 2030, a multidisciplinary research team led by Professor Wu Chia-lin at Chang Gung University has successfully commercialized an innovative "Probiotic Efficacy Screening Platform" leveraging Drosophila melanogaster (fruit flies) as a bridge model to target the gut-brain axis for cognitive health.